42 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Novartis (NVS) Gets Approval for MS Drug Mayzent in Europe http://www.zacks.com/stock/news/728495/novartis-nvs-gets-approval-for-ms-drug-mayzent-in-europe?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-728495 Jan 21, 2020 - Novartis' (NVS) MS drug, Mayzent, obtains approval in Europe for the treatment of adult patients with secondary progressive multiple sclerosis.
Teva's Two Pivotal Studies on Ajovy in Japan Meet Goal http://www.zacks.com/stock/news/748888/tevas-two-pivotal-studies-on-ajovy-in-japan-meet-goal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-748888 Feb 04, 2020 - Teva (TEVA) posts positive results from two phase II/III studies on Ajovy for treating patients with chronic and episodic migraine in Japan.
Teva Reports Q4 Earnings Beat http://feeds.benzinga.com/~r/benzinga/~3/tEL9UqI1Dk4/teva-reports-q4-earnings-beat Feb 12, 2020 -

Teva Pharmaceutical Indus (NYSE: TEVA) reported fourth-quarter earnings of 64 cents per share, which beat the analyst consensus estimate of 61 cents by 4.92%. This is a 20.75% increase over earnings of 53 cents per share from the same period last year.

read more

Teva (TEVA) Q4 Earnings In Line, Sales Beat, Stock Up http://www.zacks.com/stock/news/761874/teva-teva-q4-earnings-in-line-sales-beat-stock-up?cid=CS-ZC-FT-tale_of_the_tape|earnings_report-761874 Feb 12, 2020 - Teva Pharmaceutical (TEVA) matches earnings estimates but beats the same for sales. Shares rise in pre-market trading.
Why Teva Pharmaceutical Is Rallying 10% Today https://www.fool.com/investing/2020/02/12/why-teva-pharmaceutical-is-rallying-10-today.aspx?source=iedfolrf0000001 Feb 12, 2020 - The company's latest financial results are sparking investor optimism.
Teva Pharmaceutical Industries Limited 2019 Q4 - Results - Earnings Call Presentation https://seekingalpha.com/article/4323413-teva-pharmaceutical-industries-limited-2019-q4-results-earnings-call-presentation?source=feed_tag_israel Feb 12, 2020 - The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2019 Q4 earnings call.
Leaner, More Agile Teva Has Brighter Days Ahead http://www.gurufocus.com/news/1038203/leaner-more-agile-teva-has-brighter-days-ahead Feb 13, 2020 - Leaner, More Agile Teva Has Brighter Days Ahead, Stocks: TEVA,AMGN,LLY, release date:Feb 13, 2020
Leaner, More Agile Teva Sees Brighter Days Ahead http://www.gurufocus.com/news/1038203/leaner-more-agile-teva-sees-brighter-days-ahead Feb 13, 2020 - Leaner, More Agile Teva Sees Brighter Days Ahead, Stocks: TEVA,AMGN,LLY, release date:Feb 13, 2020
Teva: The Road To Perdition Has Turned Into A Path Towards Redemption https://seekingalpha.com/article/4325166-teva-road-to-perdition-turned-path-towards-redemption?source=feed_tag_israel Feb 19, 2020 - Stock price has bounced significantly, debt load has declined substantially, and bond yields have fallen meaningfully.More than anything, the recent earnings report has proven that the company remains
3 Reasons Why Teva Pharmaceutical Is Still A Good Buy https://seekingalpha.com/article/4325291-3-reasons-why-teva-pharmaceutical-is-still-good-buy?source=feed_tag_israel Feb 19, 2020 - Teva exceeded market expectations in the fourth quarter.Prospects continue to improve, driven by strong generic pipeline and two drugs.Fair value on Teva stock modelled.

Pages: 12345

<<<Page 4